Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 252 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Comparative Analysis of Denosumab and Zoledronic Acid in Advanced Breast Cancer Patients Receiving CDK4/6 Inhibitors
Roberta Scafetta, Marco Donato, Carla Gullotta, Alessandra Guarino, Cristina Fiore, Luisana Sisca, Elena Speziale, Raffaella Troiano, Simone Foderaro, Valentina Ricozzi,Michele Iuliani,Sonia Simonetti, Silvia Cavaliere,Alessio Cortellini,Andrea Botticelli,Simone Scagnoli, Simona Pisegna,Carmen Criscitiello,Rebecca Pedersini,Caterina Sposetti, Elisa Tiberi, Giuliana D'Auria,Matteo Vergati,Marco Mazzotta,Roberta Caputo, Annarita Verrazzo, Maria Grazia Rossino,Federica Domati, Claudia Piombino, Francesca Sofia Di Lisa, Lorena Filomeno, Teresa Arcuri, Federica Puce, Federica Riva,Michela Palleschi, Marianna Sirico,Marta Piras,Luigia Stefania Stucci,Delia De Lisi, Paolo Orsaria,Edy Ippolito,Sara Ramella,Luca Visani, Niccolò Bertini,Ilaria Bonaparte,Stefania Gori,Luigi Rossi,Icro Meattini, Barbara Tagliaferri,Orazio Caffo,Ilaria Portarena,Azzurra Irelli,Elisabetta Cretella,Camillo Porta,Giampaolo Bianchini,Agnese Fabbri,Ugo De Giorgi,Patrizia Vici,Angela Toss,Ornella Garrone,Michelino De Laurentiis, Federica Villa,Rossana Berardi,Mauro Minelli,Claudio Vernieri,Giuseppe Curigliano,Bruno Vincenzi,Giuseppe Tonini,Daniele Santini,Francesco Pantano
Breast (Edinburgh, Scotland) (2025): 104502-104502
Cited0Views0WOSBibtex
0
0
Atezolizumab Plus Paclitaxel and Bevacizumab As First-Line Treatment of Advanced Triple-Negative Breast Cancer: the ATRACTIB Phase 2 Trial
María Gion,Isabel Blancas, Patricia Cortez-Castedo,Alfonso Cortés-Salgado,Frederik Marmé, Salvador Blanch, Serafín Morales, Nieves Díaz, Isabel Calvo-Plaza, Sabela Recalde, Alejandro Martínez-Bueno,Manuel Ruiz-Borrego,Elisenda Llabrés, María Teresa Taberner,Michelino de Laurentiis, Silvia García-Vicente, José Antonio Guerrero, Olga Boix, Jose Rodríguez-Morató,Miguel Sampayo-Cordero,Gabriele Antonarelli,José Manuel Pérez-García,Javier Cortés,Antonio Llombart-Cussac, ATRACTIB Trial Investigators
Nature medicine (2025)
Cited0Views0WOSBibtex
0
0
Prognostic Implications of Risk Definitions from the Monarche and NATALEE Trials
Luca Arecco, Eva Blondeaux,Marco Bruzzone,Grazia Arpino,Carmine De Angelis,Michelino De Laurentiis,Roberta Caputo,Alessandra Fabi,Valeria Sanna,Stefania Gori,Fabio Puglisi,Luca Boni, Simone Nardin, Irene Giannubilo, Marta Perachino, Roberto Borea, Elisa Agostinetto,Evandro de Azambuja,Matteo Lambertini,Lucia Del Mastro
Journal of the National Cancer Instituteno. 6 (2025): 1198-1208
Cited0Views0WOSBibtex
0
0
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
Mario Campone,Michelino De Laurentiis,Komal Jhaveri,Xichun Hu,Sylvain Ladoire,Anne Patsouris,Claudio Zamagni, Jiuwei Cui, Marina Cazzaniga,Timucin Cil, Katarzyna J Jerzak, Christian Fuentes,Tetsuhiro Yoshinami,Alvaro Rodriguez-Lescure,Ahmet Sezer,Andrea Fontana,Valentina Guarneri, Andrea Molckovsky, Marie-Ange Mouret-Reynier, Umut Demirci, Yongqiang Zhang,Olga Valota,Dongrui R Lu, Marcella Martignoni, Janaki Parameswaran, Xin Zhi, Erika P Hamilton, VERITAC-2 Study Group
The New England journal of medicine (2025)
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 252

#Citation: 7848

H-Index: 41

G-Index: 86

Sociability: 7

Diversity: 3

Activity: 203

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn